Organizers of the Save HIV Funding Campaign outside the U.S. Capitol on Sept. 5. (Paul Morigi / Getty Images for Save HIV Funding Campaign ) To become law, any funding bill must pass both chambers of ...
Given that much of our coverage concerns gloomy topics like conflict, humanitarian crises and political discord, it always feels like a breath of fresh air when we’re able to spotlight a good-news ...
Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and highly effective HIV prevention drug for roughly $40 per year beginning in ...
The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...
Two Indian drugmakers, Hetero Pharma & Dr Reddy’s Laboratories, set to produce generic lenacapavir. The generic version will be available in low- and middle-income countries at significantly lower ...
Gilead's groundbreaking HIV prevention drug will soon be available at a fraction of its U.S. price in over 100 countries, thanks to new partnerships with generic manufacturers.
Infectious disease experts have hailed a move that will see a highly effective HIV prevention drug be sold at just 40 dollars a year in low and middle income countries. Deals with Indian drug ...
A twice-yearly Human Immunodeficiency Virus prevention injection, hailed as the most promising tool against the virus in decades, has generated mixed ...
India is in the process of approving lenacapavir, a new HIV prevention drug you only need twice a year—no more daily pills. It's almost 100% effective per dose and costs just $40 a year in low- and ...
A game-changing HIV prevention drug is set to become vastly more affordable in over 100 low- and middle-income countries, a move that could bring the world closer to ending the HIV/AIDS epidemic.
Hetero and Dr Reddy’s will be funded by the Gates Foundation and Unitaid to produce and sell the twice-a-year anti-HIV shot around R692 per person a year ...